2021
Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis
Li AX, Resio BJ, Canavan ME, Papageorge M, Boffa DJ, Blasberg JD. Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis. Journal Of Thoracic Disease 2021, 0: 0-0. PMID: 34277037, PMCID: PMC8264694, DOI: 10.21037/jtd-21-1.Peer-Reviewed Original ResearchPrimary lung sarcomaNational Cancer DatabaseLung sarcomaOverall survivalSurgical resectionMultivariable Cox proportional hazards modelsNon-small cell lung cancer patientsNational Cancer Database AnalysisCell lung cancer patientsCox proportional hazards modelCharlson-Deyo scoreFive-year OSMultivariable Cox modelPositive lymph nodesMajority of patientsLung cancer patientsHigh tumor gradeHigh-grade tumorsDifferent histologic subtypesProportional hazards modelAdjuvant chemotherapyParenchymal resectionPulmonary malignancyWorse survivalAdjusted mortalityHigh expression of cell adhesion molecule 2 unfavorably impacts survival in non-small cell lung cancer patients with brain metastases
Dai L, Li YH, Liang YY, Zhao J, Chen G, Yin J, Postmus PE, Addeo A, Blasberg JD, Onesti CE, Liao ZW, Rao XG, Long HD. High expression of cell adhesion molecule 2 unfavorably impacts survival in non-small cell lung cancer patients with brain metastases. Journal Of Thoracic Disease 2021, 13: 2437-2446. PMID: 34012591, PMCID: PMC8107517, DOI: 10.21037/jtd-21-307.Peer-Reviewed Original ResearchNon-small cell lung cancer patientsCell lung cancer patientsBrain metastasesKaplan-Meier analysisNSCLC patientsLung cancer patientsCell adhesion molecule 2Overall survivalCox analysisPoor prognosisCancer patientsAffiliated Cancer HospitalHigh expressionIndependent risk factorSolid organ malignanciesOS of patientsCADM2 expressionLymph node metastasisTumor T stagePotential prognostic significanceGuangzhou Medical UniversityExpression levelsReal-time polymerase chain reactionQuantitative real-time polymerase chain reactionChi-square test
2019
Quantitative FDG PET/CT may help risk-stratify early-stage non-small cell lung cancer patients at risk for recurrence following anatomic resection
Harmon S, Seder CW, Chen S, Traynor A, Jeraj R, Blasberg JD. Quantitative FDG PET/CT may help risk-stratify early-stage non-small cell lung cancer patients at risk for recurrence following anatomic resection. Journal Of Thoracic Disease 2019, 11: 1106-1116. PMID: 31179052, PMCID: PMC6531752, DOI: 10.21037/jtd.2019.04.46.Peer-Reviewed Original ResearchDisease-free survivalSquamous cell carcinomaNon-small cell lung cancer patientsStandardized uptake valueCell lung cancer patientsEarly-stage NSCLCLung cancer patientsDisease recurrenceAnatomic resectionOverall survivalCancer patientsF-fluorodeoxyglucose positron emission tomography/computerized tomographyEarly stage non-small cell lung cancer patientsStage I/II NSCLC patientsPositron emission tomography/computerized tomographyCox proportional hazards regressionFDG PET/CTTomography/computerized tomographyQuantitative FDG-PET/CTPathologic node statusYears of resectionPreoperative risk factorsHigh-risk patientsSignificant univariate predictorsPrimary tumor volume